Compass Therapeutics Stock Forecast

Buy or Hold candidate since Jun 22, 2026 Loss -1.90%

The Compass Therapeutics, Inc. stock price fell by -1.90% on the last day (Tuesday, 23rd Jun 2026) from $2.10 to $2.06. During the last trading day the stock fluctuated 3.43% from a day low at $2.04 to a day high of $2.11. The price has risen in 6 of the last 10 days and is up by 1.98% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -316 thousand shares and in total, 3 million shares were bought and sold for approximately $6.22 million.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $1.16, a level that may pose a second chance to hit a runner. According to fan-theory $3.37 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CMPX Signals & Forecast

The Compass Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.04 and $2.02. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -14.52%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Compass Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.84 and $1.79. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Compass Therapeutics, Inc. finds support just below today's level at $1.84. If this is broken, then the next support from accumulated volume will be at $1.79 and $1.67.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0700 between high and low, or 3.43%. For the last week, the stock has had daily average volatility of 5.17%.

Our recommended stop-loss: $1.96 (-4.89%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 17 days ago.)

Trading Expectations (CMPX) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Compass Therapeutics, Inc. to open at $2.07, and during the day (based on 14 day Average True Range), to move between $1.98 and $2.14, which gives a possible trading interval of +/-$0.158 (+/-7.96%) up or down from last closing price. If Compass Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.10 (1.94%) than the support at $1.84 (10.68%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Compass Therapeutics, Inc. stock A Buy?

Compass Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: -0.029 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $2.07 ( 0.485%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk